Medingo, Ltd.
IsraelFDA applicant, unverified
- Devices
- 2
What Medingo, Ltd. makes
Medingo, Ltd. manufactures insulin delivery systems, including the SOLO Insulin Patch Pump and the SOLO Micropump Insulin Delivery System, designed for continuous subcutaneous insulin administration.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Solo Insulin Patch Pump Ref K090245
Regimes: 510(k) Registry: 510(k)Solo Micropump Insulin Delivery System Ref K093364
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Medingo, Ltd. have in the registry?
The registry currently lists 2 devices for Medingo, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Medingo, Ltd.'s devices?
Among its 2 most recently registered devices, Medingo, Ltd. has devices listed in FDA 510(k) (2 devices).
What risk classes do Medingo, Ltd.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Medingo, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Medingo, Ltd. in the registry?
The most recently registered devices listed for Medingo, Ltd. include SOLO INSULIN PATCH PUMP and SOLO MICROPUMP INSULIN DELIVERY SYSTEM.